BMS to buy Celgene in deal worth $74 billion

Thursday, January 3, 2019 - 12:30 in Mathematics & Economics

The mega-merger will create a leading oncology drug company

Read the whole article on C&EN

More from C&EN

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net